Physician

Afsana Qader, DPM

According to 2025 Medicare claims, Afsana Qader, DPM (NPI: 1497808638) practices podiatry in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Westchester, NY. This provider's primary affiliated billing organization is AFSANA QADER, DPM P.C. (NPI: 1972840445) and primary practice location at 10701-1319.

Qader's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 181 traditional Medicare patients, billed 614 HCPCS/CPT codes, and received $38,869 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 436 prescription claims across 154 beneficiaries totaling $28,155 in drug costs, led by Jublia (Efinaconazole). DME data shows 49 claims. Open Payments data shows 2 records totaling $265. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $80,816 to $38,869. In contrast, Part D prescription costs have moved sharply higher in recent years, from $13,069 to $28,155. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $0 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	314	1,508	$80,816
2016	393	1,495	$81,554
2017	352	1,651	$92,470
2018	332	1,784	$105,563
2019	410	2,157	$128,381
2020	318	1,187	$68,196
2021	244	1,019	$68,104
2022	196	808	$54,317
2023	230	936	$58,887
2024	181	614	$38,869

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	56	118	$13,069
2016	49	94	$5,920
2017	63	122	$5,835
2018	54	115	$4,378
2019	70	158	$3,604
2020	105	288	$9,670
2021	131	330	$10,347
2022	129	314	$10,000
2023	151	436	$15,938
2024	154	436	$28,155

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	152	152	$18,654
2016	79	79	$9,529
2017	103	103	$12,698
2018	92	92	$11,293
2019	147	147	$18,442
2020	102	102	$12,930
2021	105	105	$13,569
2022	78	78	$10,385
2023	100	100	$14,224
2024	49	49	$7,201

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	33	33	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	142	313	$77
11721	Removal of fingernails or toenails, 6 or more nails	104	207	$38
73630	X-ray of foot, minimum of 3 views	14	25	$32

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jublia	Efinaconazole	12	360	$16,144
Doxepin Hcl	Doxepin Hcl	30	900	$3,442
Ciclopirox	Ciclopirox Olamine	47	2,044	$2,028
Clotrimazole	Clotrimazole	65	1,775	$1,688
Ammonium Lactate	Ammonium Lactate	100	4,653	$1,674

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A5512	For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each	N	23	23	$3,703
A5500	For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe	N	26	26	$3,498

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$265	Advanced Oxygen Therapy Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Afsana Qader, DPM?

Tedicare shows public-source Medicare data for Afsana Qader, DPM (NPI 1497808638), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Afsana Qader, DPM have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Afsana Qader, DPM?

Afsana Qader, DPM is linked to AFSANA QADER, DPM P.C. (billing NPI 1972840445) in the available physician profile data.

Does Afsana Qader, DPM have Open Payments data?

Afsana Qader, DPM has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.